Last update 01 Nov 2024

IgG x ASGR1

Basic Info

Related Targets
IgGASGR1

Related

1
Drugs associated with IgG x ASGR1
BHV-1300
Target
ASGR1 x IgG
Mechanism
ASGR1 modulators [+1]
Active Org.
Biohaven Ltd.
Originator Org.
Biohaven Ltd.
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with IgG x ASGR1
ACTRN12624001129572 / Not yet recruitingPhase 1
Evaluating Multiple Doses of an Optimized Subcutaneous Formulation of BHV-1300 in Healthy Adults in a Phase 1, Randomized, Open-Label, Placebo-Controlled Study
100 Clinical Results associated with IgG x ASGR1
Login to view more data
100 Translational Medicine associated with IgG x ASGR1
Login to view more data
0 Patents (Medical) associated with IgG x ASGR1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free